Synthetic polymeric vectors in gene therapy

Current Opinion in Solid State and Materials Science

Volumn 12, Issue 5-6, 2008, Pages 89-102

  Kundu, Patit P ^a   Sharma, Vinay ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Gene therapy; Non viral therapy; pDNA; Polymeric vectors

Indexed keywords

AMINO ESTERS; GENE THERAPY; HUMAN GENOME PROJECT; LOW LEVEL; NON-VIRAL THERAPY; NONVIRAL; PDNA; POLYAMIDOAMINE DENDRIMERS; POLYETHYLENIMINE; POLYMERIC VECTORS; SYNTHETIC POLYMERS; TRANSFECTION EFFICIENCY;

AMINES; DENDRIMERS; ESTERS; GENETIC ENGINEERING; NUCLEIC ACIDS; ONCOGENIC VIRUSES;

VECTORS;

EID: 67349148547     PISSN: 13590286     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cossms.2009.01.005     Document Type: Review

References (121)

1. Mulligan R.C. The basic science of gene therapy. Science 260 (1993) 926-932
2. Lozier J.N., and Brinkhous K.M. Gene therapy and the hemophilias. J Am Med Assoc 271 (1994) 47-51
3. Inui K., Okada S., and Dickson G. Gene therapy in Duchenne muscular dystrophy. Brain Dev 18 (1996) 357-361
4. Hartigan-O'Connor D., and Chamberlain J.S. Progress toward gene therapy of Duchenne muscular dystrophy. Sem Neurol 19 (1999) 323-332
5. Hartigan-O'Connor D., and Chamberlain J.S. Developments in gene therapy for muscular dystrophy. Microsc Res Tech 48 (2000) 223-238
6. Alton E.W.F.W., Geddes D.M., Gill D.R., Higgins C.F., Hyde S.C., Innes J.A., et al. Towards gene therapy for cystic fibrosis: a clinical progress report. Gene Ther 5 (1998) 291-292
7. Nabel E.G. Gene therapy for cardiovascular diseases. J Nucl Cardiol 6 (1999) 69-75
8. Dunnett S.B., and Bjorklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399 (1999) A32-A39
9. Alisky J.M., and Davidson B.L. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases. Hum Gene Ther 11 (2000) 2315-2329
10. Barkats M., Bilang-bleuel A., Buc-caron M.H., Castelbarthe M.N., Corti O., Finiels F., et al. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. Prog Neuorbiol 55 (1998) 333-341
11. Chadwick D.R., and Lever A.M.L. Gene therapy for HIV infection. Exp Opin Ther Patents 8 (1998) 983-990
12. Bonadio J., Goldstein S.A., and Levy R.J. Gene therapy for tissue repair and regeneration. Adv Drug Delivery Rev 33 (1998) 53-69
13. Vile R.G., Russell S.J., and Lemoine N.R. Cancer gene therapy: hard lessons and new courses. Gene Ther 7 (2000) 2-8
14. Folkman J. Antiangiogenic gene therapy. Proc Natl Acad Sci USA 95 (1998) 9064-9066
15. Roth J.A., and Cristiano R.J. Gene therapy for cancer: what have we done and where are we going?. J Natl Cancer Inst 89 (1997) 21-39
16. Nabel E.G.. Gene therapy for vascular diseases. Atherosclerosis 118 (1995) S51-S56
17. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu Rev Immunol 15 (1997) 617-648
18. Vaheri A., and Pagano J.S. Infectious poliovirus RNA a sensitive method of assay. Virology 27 (1965) 434-436
19. Graham F.L., and Eb A.J.V.D. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 (1973) 456-467
20. Marshall E. Clinical trials: gene therapy death prompts review of adenovirus vector. Science 286 (1999) 2244-2245
21. Marshall E. FDA halts all gene therapy trials at Penn. Science 287 (2000) 565-567
22. Marshall E. Clinical research. Gene therapy a suspect in leukemia-like disease. Science 298 (2002) 34-35
23. Kaiser J. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial. Science 299 (2003) 495
24. Ledley F.D. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 6 (1995) 1129-1144
25. Lollo C.P., Banaszczyk M.G., and Chiou H.C. Obstacles and advances in non-viral gene delivery. Curr Opin Mol Ther 2 (2000) 136-142
26. Mislick K.A., and Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 93 (1996) 12349-12354
27. Goncalves C., Pichon C., Guerin B., and Midoux P. Intracellular processing and stability of DNA complexed with histidylated polylysine conjugates. J Gene Med 4 (2002) 271-281
28. Goncalves C., Mennesson E., Fuchs R., Gorvel J.P., Midoux P., and Pichon C. Macropinocytosis of polyplexes and recycling of plasmid via the clathrin-dependent pathway impair the transfection efficiency of human hepatocarcinoma cells. Mol Ther 10 (2004) 373-385
29. Kopatz I., Remy J.S., and Behr J.P. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med 6 (2004) 769-776
30. Ruponen M., Honkakoski P., Tammi M., and Urtti A. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J Gene Med 6 (2004) 405-414
31. Wu G.Y., and Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262 (1987) 4429-4432
32. Wagner E., Zenke M., Cotten M., Beug H., and Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 87 (1990) 3410-3414
33. Curiel D.T., Agarwal S., Wagner E., and Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 88 (1991) 8850-8854
34. Lukacs G.L., Haggie P., Seksek O., Lechardeur D., Freedman N., and Verkman A.S. Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem 275 (2000) 1625-1629
35. Ludtke J.J., Zhang G., Sebestyén M.G., and Wolff J.A. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J Cell Sci 112 (1999) 2033-2041
36. Brunner S., Furtbauer E., Sauer T., Kursa M., and Wagner E. Overcoming the nuclear barrier cell: cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther 5 (2002) 80-86
37. Schaffer D.V., Fidelman N.A., Dan N., and Lauffenburger D.A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 67 (2000) 598-606
38. Plank C., Tang M.X., Wolfe A.R., and Szoka F.C. Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum Gene Ther 10 (1999) 319-332
39. Parker A.L., Oupicky D., Dash P.R., and Seymour L.W. Methodologies for monitoring nanoparticle formation by self-assembly of DNA with poly(l-lysine). Anal Biochem 302 (2002) 75-80
40. Hardy J.G., Kostiainen M.A., Smith D.K., Gabrielson N.P., and Pack D.W. Dendrons with spermine surface groups as potential building blocks for nonviral vectors in gene therapy. Bioconjug Chem 17 (2006) 172-178
41. Reineke T.M., and Davis M.E. Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center type. Bioconjug Chem 14 (2003) 255-261
42. Reineke T.M., and Davis M.E. Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centers. Bioconjug Chem 14 (2003) 247-254
43. Gilding D.K. Biocompatibility of clinical implant materials Vol. 2 (1981), CRC Press
44. Shea L.D., Smiley E., Bonadio J., and Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17 (1999) 551-554
45. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., and Demeneix B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 7 (1996) 1947-1954
46. Ferrari S., Moro E., Pettenazzo A., Behr J.P., Zacchello F., and Scarpa M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther 4 (1997) 1100-1106
47. Chemin I., Moradpour D., Wieland S., Offensperger W.B., Walter E., Behr J.P., et al. Liverdirected gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepat 5 (1998) 369-375
48. Turunen M.P., Hiltunen M.O., Ruponen M., Virkamaki L., Szoka F.C., Urtti A., et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther 6 (1999) 6-11
49. Zou S.M., Erbacher P., Remy J.S., and Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2 (2000) 128-134
50. Ji Z., Manuel W.S., and Hornsby P.J. Transfection of cells mediated by biodegradable polymer materials with surface bound polyethlenimine. Biotechnol Prog 16 (2000) 254-257
51. Blessing T., Kursa M., Holzhauser R., Kircheis R., and Wagner E. Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjugate Chem 12 (2001) 529-537
52. Gosselin M.A., Guo W., and Lee R.J. Efficient gene transfer using reversibly cross-linked lowmolecular weight polyethylenimine. Bioconjugate Chem 12 (2001) 989-994
53. Petersen H., Kunath K., Martin A.L., Stolnik S., Roberts C.J., Davies M.C., et al. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 3 (2002) 926-936
54. Fischer D., Harpe A.V., Kunath K., Peterson H., Li Y., and Kissel T. Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. Bioconjugate Chem 13 (2002) 1124-1133
55. Tseng W.C., and Jong C.M. Improved stability of polycationic vector by dextran-grafted branched polyethylenimine. Biomacromolecules 4 (2003) 1277-1284
56. Li S., Tseng W.C., Stolz D.B., Wu S.P., Watkins S.C., and Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 6 (1999) 585-594
57. Pun S.H., Bellocq N.C., Liu A., Jensen G., Machemer T., Schluep Quijano.E., et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjugate Chem 15 (2004) 831-840
58. Gabrielson N.P., and Pack D.W. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules 7 (2006) 2427-2435
59. Forrest M.L., Meister G.E., Koerber J.T., and Pack D.W. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm Res 21 (2004) 365-371
60. Sethuraman V.A., Na K., and Bae Y.H. PH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study. Biomacromolecules 7 (2006) 64-70
61. Burke R.S., and Pun S.H. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjugate Chem 19 (2008) 693-704
62. Tomalia D.A., Naylor A.M., and Goddard W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 29 (1990) 138-175
63. Haensler J., and Szoka F.C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem 4 (1993) 372-379
64. Arima H., Kihara F., Hirayama F., and Uekama K. Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins. Bioconjugate Chem 12 (2001) 476-484
65. Arima H., Kihara F., Tsutsumi T., Hirayama F., and Uekama K. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin. Bioconjugate Chem 13 (2002) 1211-1219
66. Griffiths P.C., Paul A., Khayat Z., Wan K.W., King S.M., Grillo I., et al. Understanding the mechanism of action of poly(amidoamine)s as endosomolytic polymers: correlation of physicochemical and biological properties. Biomacromolecules 5 (2004) 1422-1427
67. Tang M.X., Redemann C., and Szoka F.C. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem 7 (1996) 703-714
68. Kim T., Seo H.J., Choi J.S., Jang H.S., Baek J., Kim K., et al. PAMAM-PEG-PAMAM: novel triblock copolymer as a biocompatible and efficient gene delivery carrier. Biomacromolecules 5 (2004) 2487-2492
69. Zhong H., He Z.G., Li Z., Li G.Y., Shen S.R., and Li X.L. Studies on polyamidoamine dendrimers as efficient gene delivery vector. J Biomater Appl (2007)
70. Cherng J.Y., van de W.P., Talsma H., Crommelin D.J., and Hennink W.E. Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res 13 (1996) 1038-1042
71. van de W.P., Cherng J.Y., Talsma H., Crommelin D.J., and Hennink W.E. 2-(Dimethylamino) ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release 53 (1998) 145-153
72. Van de W.P., Schuurmans-Nieuwenbroek N.M., Hennink W.E., and Storm G. Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. J Gene Med 1 (1999) 156-165
73. Verbaan F.J., Oussoren C., van Dam I.M., Takakura Y., Hashida M., Crommelin D.J., et al. The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm 214 (2001) 99-101
74. Funhoff A.M., van Nostrum C.F., Koning G.A., Schuurmans-Nieuwenbroek N.M., Crommelin D.J., and Hennink W.E. Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules 5 (2004) 32-39
75. Jiang X., Lok M.C., and Hennink W.E. Degradable-brushed PHEMA-PDMAEMA synthesized via ATRP and click chemistry for gene delivery. Bioconjugate Chem 18 (2007) 2077-2084
76. Wakebayashi D., Nishiyama N., Itaka K., Miyata K., Yamasaki Y., Harada A., et al. Polyion complex micelles of pdna with acetal-poly(ethylene glycol)-poly(2-(dimethylamino)ethyl methacrylate) block copolymer as the gene carrier system: physicochemical properties of micelles relevant to gene transfection efficacy. Biomacromolecules 5 (2004) 2128-2136
77. Kloeckner J., Bruzzano S., Ogris M., and Wagner E. Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties. Bioconjugate Chem 17 (2006) 1339-1345
78. Tan J.F., Hatton T.A., Tam K.C., and Too H.P. Correlating transfection barriers and biophysical properties of cationic polymethacrylates. Biomacromolecules 8 (2007) 448-454
79. Zhang L., Nguyen T.L.U., Bernard J., Davis T.P., Kowollik C.B., and Stenzel M.H. Shell-cross-linked micelles containing cationic polymers synthesized via the raft process: toward a more biocompatible gene delivery system. Biomacromolecules 8 (2007) 2890-2901
80. Ko I.K., Ziady A., Lu S., and Kwon Y.J. Acid-degradable cationic methacrylamide polymerized in the presence of plasmid DNA as tunable non-viral gene carrier. Biomaterials 29 (2008) 3872-3881
81. Lynn D.M., and Langer R. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 122 (2000) 10761-10768
82. Lynn D.M., Anderson D.G., Putnam D., and Langer R. Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc 123 (2001) 8155-8156
83. Akinc A., Lynn D.M., Anderson D.G., and Langer R. Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc 125 (2003) 5316-5323
84. Akinc A., and Langer R. Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol Bioeng 78 (2002) 503-508
85. Akinc A., Anderson D.G., Lynn D.M., and Langer R. Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery. Bioconjugate Chem 14 (2003) 979-988
86. Anderson D.G., Lynn D.M., and Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed 42 (2003) 3153-3158
87. Anderson D.G., Akinc A., Hossain N., and Langer R. Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther 11 (2005) 426-434
88. Green J.J., Shi J., Chiu E., Leshchiner E.S., Langer R., and Anderson D.G. Biodegradable polymeric vectors for gene delivery to human endothelial cells. Bioconjugate Chem 17 (2006) 1162-1169
89. Green J.J., Langer R., and Anderson D.G. A combinatorial polymer library approach yields insight into non-viral gene delivery. Accounts Chem Res 41 (2008) 749-759
90. Zugates G., Anderson D., Little S., Lawhorn I., and Langer R. Synthesis of poly(betaamino ester)s with thiol-reactive side chains for DNA delivery. J Am Chem Soc 128 (2006) 12726-12734
91. Green J.J., Chiu E., Leshchiner E.S., Shi J., Langer R., and Anderson D.G. Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells. Nano Lett 7 (2007) 874-879
92. Putnam D., Gentry C.A., Pack D.W., and Langer R. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci USA 98 (2001) 1200-1205
93. Green J.J., Zugates G.T., Tedford N.C., Huang Y., Griffith L.G., Lauffenburger D.A., et al. Combinatorial modification of degradable polymers enables transfection of human cells comparable to adenovirus. Adv Mater 19 (2007) 2836-2842
94. Zugates G.T., Peng W., Zumbuehl A., Jhunjhunwala S., Huang Y.H., Langer R., et al. Rapid optimization of gene delivery by parallel end modification of poly(β-amino ester)s. Mol Ther 15 (2007) 1306-1312
95. Zugates G.T., Tedford N.C., Zumbuehl A., Jhunjhunwala S., Kang C.S., Griffith L.G., et al. Gene delivery properties of end-modified poly(beta-amino ester)s. Bioconjugate Chem 18 (2007) 1887-1896
96. Anderson D.G., Peng W., Akinc A., Hossain N., Kohn A., Padera R., et al. A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci USA 101 (2004) 16028-16033
97. Little S.R., Lynn D.M., Ge Q., Anderson D.G., Puram S.V., Chen J.Z., et al. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci USA 101 (2004) 9534-9539
98. Kim T., Seo H.J., Choi J.S., Yoon J.K., Baek J., Kim K., et al. Synthesis of biodegradable cross-linked poly(β-amino ester) for gene delivery and its modification, inducing enhanced transfection efficiency and stepwise degradation. Bioconjugate Chem 16 (2005) 1140-1148
99. Lim Y., Kim S., Suh H., and Park J.S. Biodegradable, endosome disruptive and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjugate Chem 13 (2002) 952-957
100. Kopecek J., Kopeckova P., Minko T., and Lu Z. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur Pharm J Biopharm 50 (2000) 61-81
101. Harris J.M., and Chess R.B. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2 (2003) 214-221
102. Veronese F.M., and Morpurgo M. Bioconjugation in pharmaceutical chemistry. Farmaco 54 (1999) 497-516
103. Harris J.M., Martin N.E., and Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40 (2001) 539-551
104. Davis F.F., Kazo G.M., Nucci M.L., and Abuchowski A. In: Lee V.H.L. (Ed). Peptide and protein drug delivery (1990), Dekker, New York 226
105. Nucci M.L., Schorr R., and Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Deliv Rev 6 (1991) 133-151
106. Russell-Jones G.J. The potential use of receptor-mediated endocytosis for oral drug delivery. Adv Drug Deliv Rev 20 (1996) 83-97
107. Okamoto C.T. Endocytosis and transcytosis. Adv Drug Deliv Rev 29 (1998) 215-228
108. Takakura Y., Mahoto R.I., and Hashida M. Extravasation of macromolecules. Adv Drug Deliv Rev 34 (1998) 93-108
109. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2 (2002) 750-763
110. Ogris M., Brunner S., Schuller S., Kircheis R., and Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6 (1999) 595-605
111. Toncheva V., Wolfert M.A., Dash P.R., Oupicky D., Ulbrich K., Seymour L.W., et al. Novel vectors for gene delivery formed by self-assembly of DNA with poly(l-lysine) grafted with hydrophilic polymers. Biochim Biophys Acta 1380 (1998) 354-368
112. Banaszczyk M.G., Lollo C.P., Kwoh D.Y., Phillips A.T., Amini A., Wu D.P., et al. Poly-l-lysine-graft-PEG comb-type polycation copolymers forgene delivery. J Macromol Sci A 36 (1999) 1061-1084
113. Putnam D., Zelikin A.N., Izumrudov V.A., and Langer R. Polyhistidine-PEG: DNA nanocomposites for gene delivery. Biomaterials 24 (2003) 4425-4433
114. Zhang Y., Zhu S., Yin L., Qian F., Tang C., and Yin C. Preparation, characterization and biocompatibility of poly(ethylene glycol)-poly(n-butyl cyanoacrylate) nanocapsules with oil core via miniemulsion polymerization. Eur Polym J 44 (2008) 1654-1661
115. Oishi M., Kataoka K., and Nagasaki Y. PH-Responsive three-layered pegylated polyplex micelle based on a lactosylated abc triblock copolymer as a targetable and endosome-disruptive nonviral gene vector. Bioconjugate Chem 17 (2006) 677-688
116. Lin S., Du F., Wang Y., Ji S., Liang D., Yu L., et al. An acid-labile block copolymer of PDMAEMA and PEG as potential carrier for intelligent gene delivery systems. Biomacromolecules 9 (2008) 109-115
117. Ihm J.E., Han K.O., Han I.K., Ahn K.D., Han D.K., and Cho C.S. High transfection efficiency of poly(4-vinylimidazole) as a new gene carrier. Bioconjugate Chem 14 (2003) 707-708
118. Wittmar M., Ellis J.S., Morell F., Unger F., Schumacher J.C., Roberts C.J., et al. Biophysical and transfection studies of an amine-modified poly(vinyl alcohol) for gene delivery. Bioconjugate Chem 16 (2005) 1390-1398
119. Boussif O., Delair T., Brua C., Veron L., Pavirani A., and Kolbe H.V.J. Synthesis of polyallylamine derivatives and their use as gene transfer vectors In Vitro. Bioconjugate Chem 10 (1999) 877-883
120. Zelikin A.N., Putnam D., Shastri P., Langer R., and Izumrudov V.A. Aliphatic ionenes as gene delivery agents: elucidation of structure-function relationship through modification of charge density aand polymer length. Bioconjugate Chem 13 (2002) 548-553
121. Mumper R.J., Duguid J.G., Anwer K., Barron M.K., Nitta H., and Rolland A.P. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm Res 13 (1996) 701-709